Naltrexone Initiation and Alcohol Use
No, you do not need to stop drinking alcohol before starting naltrexone for alcohol use disorder, but you must be completely opioid-free for at least 7-10 days to avoid precipitating severe, potentially life-threatening opioid withdrawal. 1
Critical Pre-Treatment Requirements
Opioid-Free Status (Mandatory)
- Patients must be off all opioids, including opioid-containing medicines, for a minimum of 7-10 days before starting naltrexone to avoid precipitation of opioid withdrawal. 1
- Patients transitioning from buprenorphine or methadone may be vulnerable to precipitation of withdrawal symptoms for as long as two weeks. 1
- Precipitated opioid withdrawal can be severe enough to require hospitalization and intensive care unit management, with symptoms including confusion, somnolence, visual hallucinations, and significant fluid losses from vomiting and diarrhea. 1
- Even patients with negative urine toxicology screens or those who tolerate a naloxone challenge test may still experience precipitated withdrawal, particularly when transitioning from buprenorphine. 1
Alcohol Use Status (Not a Barrier)
- Naltrexone can be initiated while a patient is still drinking alcohol—there is no requirement for alcohol abstinence before starting treatment. 2, 3
- Trials not requiring lead-in abstinence from alcohol reported larger reductions in heavy drinking days per month (WMD -2.0,95% CI = -3.52, -0.48). 3
- Naltrexone works by blocking opioid receptors and dampening activation of the reward pathway by alcohol, thereby decreasing excessive drinking and increasing abstinence duration. 2
Liver Function Assessment (Essential)
- Baseline liver function tests must be performed before initiating naltrexone, as the medication can cause hepatocellular injury, particularly at higher doses. 2, 4, 1
- Naltrexone is contraindicated in patients with acute hepatitis or decompensated liver disease. 4, 1
- Liver function tests should be monitored every 3-6 months during treatment. 2, 4
- Naltrexone exposure increases approximately 5-fold in compensated cirrhosis and 10-fold in decompensated cirrhosis compared to normal liver function. 1
Key Distinction: Alcohol vs. Opioid Dependence
For Alcohol Use Disorder
- Patients can start naltrexone while actively drinking—no alcohol-free period is required. 2, 3
- The medication is designed to reduce cravings and drinking behavior in patients who are still consuming alcohol. 2, 5
- Extended-release naltrexone reduces drinking days by 2 days per month and heavy drinking days by 1.2 days per month compared to placebo. 3
For Opioid Use Disorder
- Patients must be completely opioid-free for 7-10 days (or up to 2 weeks for buprenorphine/methadone) before starting naltrexone. 1
- This requirement applies even to patients being treated primarily for alcohol dependence who may have concurrent opioid use. 1
Assessment Protocol Before Initiation
Screen All Patients for Opioid Use
- All patients, including those with alcohol dependence, must be assessed for underlying opioid dependence and any recent opioid use prior to initiation. 1
- Precipitated opioid withdrawal has been observed in alcohol-dependent patients when prescribers were unaware of additional opioid use or co-dependence. 1
- Patients should be encouraged to give an accurate account of last opioid use, as there is no completely reliable method for determining adequate opioid-free period. 1
Verify Absence of Opioid Withdrawal Symptoms
- Patients should not take naltrexone if they have any symptoms of opioid withdrawal. 1
- Symptoms of withdrawal precipitated by naltrexone typically appear within 5 minutes of ingestion and can last up to 48 hours. 1
Treatment Considerations
Duration and Efficacy
- Naltrexone's suppressant effects on drinking are most pronounced in the first 3 months of treatment. 6
- Trials lasting longer than 3 months reported larger reductions in heavy drinking days per month (WMD -1.9,95% CI = -3.2, -0.5). 3
- Many clinicians recommend one year of treatment, though optimal duration has not been well established. 5
Combination with Psychosocial Support
- Naltrexone must always be combined with psychosocial interventions such as cognitive behavioral therapy or motivational enhancement therapy for maximum efficacy. 2, 7, 1
- The medication has been shown to be effective only when used as part of a comprehensive treatment program that includes counseling and support. 1
Common Pitfalls to Avoid
- Never initiate naltrexone without thoroughly screening for recent opioid use, even in patients presenting solely for alcohol treatment. 1
- Do not assume a negative urine drug screen guarantees safety—some patients have experienced precipitated withdrawal despite negative screens. 1
- Avoid using naltrexone in patients with acute hepatitis, decompensated cirrhosis, or significantly elevated baseline transaminases. 4, 1
- Do not fail to warn patients that they will not experience effects from opioid-containing medications (analgesics, antidiarrheals, antitussives) while on naltrexone. 1
- Remember that patients who discontinue naltrexone have increased risk of opioid overdose due to decreased tolerance. 2, 1